EDGAR Filing Documents for 0001193125-20-167717

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-20-167717

Filing Date

2020-06-12

Accepted

2020-06-12 16:23:08

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d942972ds3.htm	S-3	414132
2	EX-1.2	d942972dex12.htm	EX-1.2	182031
3	EX-4.2	d942972dex42.htm	EX-4.2	339905
4	EX-4.3	d942972dex43.htm	EX-4.3	331106
5	EX-4.4	d942972dex44.htm	EX-4.4	38970
6	EX-4.5	d942972dex45.htm	EX-4.5	38755
7	EX-5.1	d942972dex51.htm	EX-5.1	33270
8	EX-23.1	d942972dex231.htm	EX-23.1	2355
9	GRAPHIC	g942972137.jpg	GRAPHIC	6442
10	GRAPHIC	g942972137a.jpg	GRAPHIC	1834
11	GRAPHIC	g942972g02n04.jpg	GRAPHIC	86491
12	GRAPHIC	g942972g02n32.jpg	GRAPHIC	78757
13	GRAPHIC	g942972g02n49.jpg	GRAPHIC	75790
14	GRAPHIC	g942972g13s17.jpg	GRAPHIC	76958
	Complete submission text file	0001193125-20-167717.txt		1831919

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140

Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340

Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)